logo
Share SHARE
FONT-SIZE Plus   Neg

Abbott: MitraClip Reduces Severity Of Mitral Regurgitation In One-year Study

Abbott (ABT) reported favorable one-year outcomes from the study of real-world experience for the MitraClip system in transcatheter mitral valve repair procedures in the U.S. The study analyzed data from the Transcatheter Valve Therapy registry involving nearly 3,000 degenerative mitral regurgitation patients who were high-risk for surgery. The company said, following implantation with MitraClip, patients had significant improvements, including 92.8 percent of patients achieving post-procedural mitral regurgitation severity grade of less than or equal to 2. In addition, 80.0 percent of MitraClip patients remained free from heart failure re-hospitalization in the year after implantation.

Mitral regurgitation is a life-threatening disease in which the leaflets of the mitral valve do not close completely, causing blood to flow backward and leak into the left atrium of the heart during the cardiac cycle.

by RTT Staff Writer

For comments and feedback: editorial@rttnews.com

Business News

Quick Facts

Editors Pick
Cable-cutters have now one more reason to do so as live television streaming will be available on YouTube TV in 14 more markets in the U.S. Facebook Chief Operating Officer Sheryl Sandberg has donated nearly $100 million in Facebook shares to charity. This is her second charitable donation within a year. A document was filed on Thursday with the Security and Exchange Commission, which shows that Sandberg transferred shares to a special fund she uses for charitable donations. Ford Motor Co.'s new CEO Jim Hackett has taken a more cautious approach to the automaker's plans for rolling out autonomous vehicles. Ford is currently undertaking a 100-day review of its operations and Hackett indicated at delays to the company's plans to launch a fully-autonomous vehicle by 2021.
comments powered by Disqus
Follow RTT